Healthcare provider profile · identity verified

Neil Smith, M.D.

Family Practice · LAWRENCE, NY · NPI 1104807981

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	447	143
Amlodipine Besylate	Amlodipine Besylate	444	128
Losartan Potassium	Losartan Potassium	297	85
Metoprolol Succinate	Metoprolol Succinate	249	74
Pantoprazole Sodium	Pantoprazole Sodium	209	65
Levothyroxine Sodium	Levothyroxine Sodium	203	56
Rosuvastatin Calcium	Rosuvastatin Calcium	190	67
Metformin Hcl	Metformin Hcl	180	57
Famotidine	Famotidine	174	44
Omeprazole	Omeprazole	161	48
Ozempic	Semaglutide	134	26
Hydrochlorothiazide	Hydrochlorothiazide	131	42
Glimepiride	Glimepiride	130	32
Atenolol	Atenolol	129	38
Albuterol Sulfate Hfa	Albuterol Sulfate	128	37
Mounjaro	Tirzepatide	128	28
Gabapentin	Gabapentin	125	39
Azithromycin	Azithromycin	122	95
Jardiance	Empagliflozin	121	34
Eliquis	Apixaban	118	23
Alprazolam	Alprazolam	116	35
Tamsulosin Hcl	Tamsulosin Hcl	114	39
Furosemide	Furosemide	108	34
Simvastatin	Simvastatin	107	30
Metformin Hcl Er	Metformin Hcl	94	34
Trulicity	Dulaglutide	90	19
Lisinopril	Lisinopril	85	26
Methylprednisolone	Methylprednisolone	85	71
Meloxicam	Meloxicam	84	28
Enalapril Maleate	Enalapril Maleate	80	21
Zolpidem Tartrate	Zolpidem Tartrate	78	20
Farxiga	Dapagliflozin Propanediol	77	21
Olmesartan Medoxomil	Olmesartan Medoxomil	75	19
Clopidogrel	Clopidogrel Bisulfate	74	22
Trazodone Hcl	Trazodone Hcl	73	25
Tizanidine Hcl	Tizanidine Hcl	72	41
Ezetimibe	Ezetimibe	68	21
Montelukast Sodium	Montelukast Sodium	68	21
Fluticasone Propionate	Fluticasone Propionate	64	31
Januvia	Sitagliptin Phosphate	62	20
Carvedilol	Carvedilol	61	16
Synthroid	Levothyroxine Sodium	61	18
Cefdinir	Cefdinir	56	48
Escitalopram Oxalate	Escitalopram Oxalate	56	16
Pravastatin Sodium	Pravastatin Sodium	55	17
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	54	13
Lovastatin	Lovastatin	53	17
Quetiapine Fumarate	Quetiapine Fumarate	49	11
Metoprolol Tartrate	Metoprolol Tartrate	48	17
Triamcinolone Acetonide	Triamcinolone Acetonide	48	28
Allopurinol	Allopurinol	47	15
Alendronate Sodium	Alendronate Sodium	46	19
Rybelsus	Semaglutide	46	suppressed
Tramadol Hcl	Tramadol Hcl	43	24
Labetalol Hcl	Labetalol Hcl	41	12
Duloxetine Hcl	Duloxetine Hcl	40	11
Ramipril	Ramipril	39	11
Tradjenta	Linagliptin	38	suppressed
Cephalexin	Cephalexin	37	29
Linzess	Linaclotide	37	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	35	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	34	suppressed
Diazepam	Diazepam	34	suppressed
Hydralazine Hcl	Hydralazine Hcl	33	11
Lidocaine	Lidocaine	33	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	33	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	33	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	30	27
Ketoconazole	Ketoconazole	29	17
Finasteride	Finasteride	28	11
Breo Ellipta	Fluticasone/Vilanterol	25	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	25	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Sertraline Hcl	Sertraline Hcl	23	suppressed
Valsartan	Valsartan	23	suppressed
Clobetasol Propionate	Clobetasol Propionate	22	14
Donepezil Hcl	Donepezil Hcl	22	suppressed
Myrbetriq	Mirabegron	22	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	22	suppressed
Potassium Chloride	Potassium Chloride	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	21	16
Glipizide	Glipizide	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	11
Valacyclovir	Valacyclovir Hcl	21	13
Alcohol Prep Pads	Alcohol Antiseptic Pads	20	11
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	20	suppressed
Fenofibrate	Fenofibrate,micronized	20	suppressed
Ondansetron Hcl	Ondansetron Hcl	20	suppressed
Temazepam	Temazepam	20	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	20	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	19	14
Nifedipine Er	Nifedipine	19	suppressed
Prednisone	Prednisone	19	17
Pregabalin	Pregabalin	19	suppressed
Entresto	Sacubitril/Valsartan	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Tresiba Flextouch U-100	Insulin Degludec	18	suppressed
Edarbyclor	Azilsartan Med/Chlorthalidone	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	17	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	16	15
Bupropion Xl	Bupropion Hcl	15	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	12
Ibuprofen	Ibuprofen	15	suppressed
Levofloxacin	Levofloxacin	15	13
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Mometasone Furoate	Mometasone Furoate	14	suppressed
Novolog Flexpen	Insulin Aspart	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Fenofibric Acid	Fenofibric Acid (Choline)	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Topiramate	Topiramate	12	suppressed
Ursodiol	Ursodiol	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Buspirone Hcl	Buspirone Hcl	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Glipizide Er	Glipizide	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Matzim La	Diltiazem Hcl	11	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error